PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors

Clinical trial NCT02022982 · COMPLETED

Trial details

NCT number: NCT02022982
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

KRAS Mutant Non-Small Cell Lung Cancer Solid Tumors

Start date: 2014-01-01
Primary completion: 2017-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.